Journal of the American Pharmacists Association

Papers
(The TQCC of Journal of the American Pharmacists Association is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Access to community pharmacies: A nationwide geographic information systems cross-sectional analysis86
COVID-19 and influenza vaccine hesitancy among college students52
The impact of the COVID-19 pandemic on medical conditions and medication adherence in people with chronic diseases44
Prevalence and risk factors of burnout in community pharmacists40
The pharmacist’s active role in combating COVID-19 medication misinformation35
Polypharmacy among COVID-19 patients: A systematic review31
Essential services: Quantifying the contributions of America’s pharmacists in COVID-19 clinical interventions29
The burden of COVID-19 on pharmacists28
Managing medication supply chains: Lessons learned from Taiwan during the COVID-19 pandemic and preparedness planning for the future28
Systemic racism: Pharmacists’ role and responsibility27
Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic27
Clinician burnout during the COVID-19 pandemic before vaccine administration25
Naloxone availability and dispensing in Indiana pharmacies 2 years after the implementation of a statewide standing order24
Screening for social determinants of health in community pharmacy: Identifying best practices, barriers, and strategies for success23
Expanded roles of community pharmacists in COVID-19: A scoping literature review23
Framework to enable pharmacist access to health care data using Blockchain technology and artificial intelligence23
Mental Health First Aid training and assessment among university students: A systematic review22
Trends in gender composition on editorial boards in leading medicine, nursing, and pharmacy journals21
The role and impact of the pharmacist in long-term care settings: A systematic review21
The clinical impact of pharmacist services on mental health collaborative teams: A systematic review20
Evaluation of naloxone access, pricing, and barriers to dispensing in Tennessee retail community pharmacies20
Reimbursement for pharmacist-provided health care services: A multistate review20
The patterns and determinants of telemedicine use during the COVID-19 crisis: A nationwide study19
Pharmacy-based pre-exposure prophylaxis support among pharmacists and men who have sex with men19
Indiana community pharmacist preceptors’ knowledge and perceptions of medication-assisted treatment19
Addressing social determinants of health in community pharmacy: Innovative opportunities and practice models19
Association between adherence and severe asthma exacerbation: A systematic review and meta-analysis18
Counterfeit drugs: A major issue for vulnerable citizens throughout the world and in the United States18
Access to naloxone at community pharmacies under the Massachusetts statewide standing order18
Assessing pharmacy-based naloxone access using an innovative purchase trial methodology18
Rethinking pharmacy regulation: Core elements of Idaho’s transition to a “Standard of Care” approach17
Revisiting pharmacy-based naloxone with pharmacists and naloxone consumers in 2 states: 2017 perspectives and evolving approaches17
The impact of pharmacist involvement on immunization uptake and other outcomes: An updated systematic review and meta-analysis17
Adolescents’ awareness about prescription opioid misuse and preferences for educational interventions16
Virtual academic detailing (e-Detailing): A vital tool during the COVID-19 pandemic16
Pharmacist counseling when dispensing naloxone by standing order: A secret shopper study of 4 chain pharmacies16
A systematic review comparing at-home diagnostic tests for SARS-CoV-2: Key points for pharmacy practice, including regulatory information16
Pharmacist-provided SARS-CoV-2 testing targeting a majority-Hispanic community during the early COVID-19 pandemic: Results of a patient perception survey16
National trends in prescription proton pump inhibitor use and expenditure in the United States in 2002-201715
Ability of the Well-Being Index to identify pharmacists in distress15
Implementing outpatient antimicrobial stewardship in a primary care office through ambulatory care pharmacist-led audit and feedback15
Pharmacy technician-administered immunizations: A five-year review15
Increasing access to care using clinical pharmacy specialist providers in outpatient mental health: Successful practice integration within the Department of Veterans Affairs15
Ensuring buprenorphine access in rural community pharmacies to prevent overdoses15
Antimicrobial stewardship by Australian community pharmacists: Uptake, collaboration, challenges, and needs14
National survey identifying community pharmacist preceptors’ experience, knowledge, attitudes, and behaviors influencing intent to recommend cannabidiol products14
Trust, influence, and community: Why pharmacists and pharmacies are central for addressing vaccine hesitancy14
Characteristics of online pharmacies selling Adderall14
Virtual pharmacist interventions on abuse of over-the-counter medications during COVID-19 versus traditional pharmacist interventions14
North Carolina community pharmacists’ buprenorphine dispensing practices and attitudes14
Attitudes about community pharmacy access to HIV prevention medications in California14
The impact of medication synchronization programs on medication adherence: A meta-analysis14
Pharmacist-led transitions-of-care services in primary care settings: Opportunities, experiences, and challenges14
Longitudinal analysis of suicides among pharmacists during 2003-201813
Perceptions, policies, and practices related to dispensing buprenorphine for opioid use disorder: A national survey of community-based pharmacists13
Community pharmacy delivered PrEP to STOP HIV transmission: An opportunity NOT to miss!13
Characteristics of older adults predict concern about stopping medications13
Effect of pharmacy-led interventions during care transitions on patient hospital readmission: A systematic review13
Δ-9-tetrahydrocannabinol dose increase leads to warfarin drug interaction and elevated INR12
Factors affecting the public’s knowledge about COVID-19 vaccines and the influence of knowledge on their decision to get vaccinated12
Exploring COVID-19 vaccine hesitancy at a rural historically black college and university12
Access to pharmacies and pharmacy services in New York City, Los Angeles, Chicago, and Houston, 2015-202012
Comparative efficacy and safety of disease-modifying therapies in patients with relapsing multiple sclerosis: A systematic review and network meta-analysis12
Hormonal contraception prescribing by pharmacists: 2019 update12
The evolving role of the pharmacist for individuals with serious mental illness12
Development of a take-home naloxone program at an urban academic emergency department12
Alaska pharmacists: First responders to the pandemic in the last frontier12
Diabetes outcomes before and during telehealth advancements surrounding COVID-1912
LGBT cultural competency, patient exposure, and curricular education among student pharmacists12
Effects of hydrocodone rescheduling on opioid use outcomes: A systematic review12
Support and perceived barriers to implementing pre-exposure prophylaxis screening and dispensing in pharmacies: Examining concordance between pharmacy technicians and pharmacists12
Using a pharmacist–community health worker collaboration to address medication adherence barriers11
Antibiotic prescribing in the emergency department versus primary care: Implications for stewardship11
The pivotal role of pharmacists during the 2019 coronavirus pandemic11
An observational survey assessing the extent of PrEP and PEP furnishing in San Francisco Bay Area pharmacies11
Patient perspectives of pharmacists prescribing HIV pre-exposure prophylaxis: A survey of patients receiving antiretroviral therapy11
Efficiencies and outcomes of depression treatment by a psychiatric pharmacist in a primary care clinic compared with treatment within a behavioral health clinic11
Association of hospital pharmacy–related knowledge and skills with occupational stress of clinical pharmacists in tertiary hospitals of China11
Pharmacists’ role, work practices, and safety measures against COVID-19: A comparative study11
Pharmacy Regulatory Innovation Index: Benchmarking the regulatory environment in 10 western states11
Nationwide estimates of medication therapy management delivery under the Medicare prescription drug benefit11
Impact of a Yin Yoga and meditation intervention on pharmacy faculty and student well-being11
Leveraging telecommuting pharmacists in the post–COVID-19 world11
Exploration of pharmacist comfort with harm reduction behaviors: Cross-sectional latent class analysis10
Perceptions of working conditions and safety concerns in community pharmacy10
Safety of intravenous push thiamine administration at a tertiary academic medical center10
The role of pharmacy technicians in vaccination services: a scoping review10
Virtual town halls addressing vaccine hesitancy among racial and ethnic minorities: Preliminary findings10
The clinical utility of professional continuous glucose monitoring by pharmacists for patients with type 2 diabetes10
Expanding access to HPV vaccination in South Carolina through community pharmacies: A geospatial analysis10
The impact of a pharmacist-led naloxone education and community distribution project on local use of naloxone10
Policy solutions to address community pharmacy working conditions10
Community pharmacist engagement in opioid use disorder prevention and treatment behaviors: A descriptive analysis10
Evaluation of patient satisfaction and perceptions of a long-acting injectable antipsychotic medication administration service in a community-based pharmacy during the COVID-19 pandemic10
Patient experiences with pharmacist prescribed hormonal contraception in California independent and chain pharmacies9
Impact of the RESPOND Toolkit on community pharmacists’ opioid safety attitudes, self-efficacy, and knowledge9
Pharmacists perceptions and preparedness regarding gender-affirming hormone therapy9
Evaluating the impact of influenza and streptococcus point-of-care testing and collaborative practice prescribing in a community pharmacy setting9
The global impact of COVID-19 on drug purchases: A cross-sectional time series analysis9
Evaluating advanced pharmacy technician roles in the provision of point-of-care testing9
Participation in emergency preparedness and response: a national survey of pharmacists and pharmacist extenders9
Community pharmacist workflow and medication therapy management delegation: An assessment of preferences and barriers9
Pharmacist impact on pneumococcal polysaccharide vaccination rates in patients with diabetes in a national grocery chain pharmacy9
Pharmacist furnishing of naloxone in California: A follow-up analysis9
Three ways to advocate for the economic value of the pharmacist in health care9
A coordinated strategy to develop and distribute infographics addressing COVID-19 vaccine hesitancy and misinformation9
Comparison of pharmacists’ mental health literacy: Developed versus developing countries9
Issues of cultural competence in mental health care9
Implementation of hormonal contraceptive furnishing in San Francisco community pharmacies9
The relationship between pharmacist emotional intelligence, occupational stress, job performance, and psychological affective well-being9
The pharmacist’s role in SARS-CoV-2 diagnostic testing9
Public awareness of Mental Health First Aid and perception of community pharmacists as Mental Health First Aid providers9
Patient perception of community pharmacists prescribing pre-exposure prophylaxis for HIV prevention9
Socialized and traumatized: Pharmacists, underserved patients, and the COVID-19 vaccine8
Health information technology utilization and impact on COVID-19 vaccination8
Community chain pharmacists’ perceptions of increased technicians’ involvement in the immunization process8
Community pharmacist collaboration with a primary care clinic to improve diabetes care8
Perspectives on prescribing hormonal contraception among rural New Mexican pharmacists8
Antimicrobial stewardship solutions with a smart innovative tool8
Community pharmacists’ perspectives about the sustainability of professional pharmacy services: A qualitative study8
Naloxone accessibility without an outside prescription from U.S. community pharmacies: A systematic review8
Gabapentin controlled substance status8
Patient perspectives of discussing social determinants of health with community pharmacists8
Telepharmacy and medication adherence in urban areas8
Strengthening pandemic preparedness through pharmacy and public health collaborations: Findings from a facilitated discussion exercise8
Rural community pharmacists’ ability and interest in administering COVID-19 vaccines in the Southern United States8
Impact of elective on students’ perceptions of treating patients with a substance use disorder8
Impact of regulatory changes on pharmacist-delivered telehealth during the COVID-19 pandemic8
Implementing comprehensive pharmacogenomics in a community hospital–associated primary care setting8
Pharmacist-led motivational interviewing for diabetes medication adherence in a worksite wellness program8
Impact of a clinical pharmacist on provider prescribing patterns in a primary care clinic8
Pharmacy deserts: More than where pharmacies are8
Pharmacist intervention in colorectal cancer screening initiative8
Effects of home drug delivery on drug-related problems: preliminary evidence for improved patient outcomes during the COVID-19 pandemic in Thailand8
Burnout and resilience among pharmacy technicians: A Singapore study8
Facilitating pneumococcal vaccination among high-risk adults: Impact of an assertive communication training program for community pharmacists8
Pharmacovigilance in patients with diabetes: A data-driven analysis identifying specific RAS antagonists with adverse pulmonary safety profiles that have implications for COVID-19 morbidity and mortal8
Increasing adult immunization rates in a rural state through targeted pharmacist education8
Older adults’ strategies for obtaining medication refills in hypothetical scenarios in the face of COVID-19 risk8
Integration of clinical pharmacists into a heart failure clinic within a safety-net hospital8
The U.S. medicine chest: Understanding the U.S. pharmaceutical supply chain and the role of the pharmacist8
A systematic review and meta-analysis of randomized controlled trials of cardiovascular toxicity of medical cannabinoids8
Factors associated with opioid-tapering success: A mixed methods study8
Pharmacist competencies for over-the-counter hearing aids: A Delphi study7
Implementation of academic detailing for pharmacists on opioid use disorder and harm reduction7
Impact of quality measures performed through pharmacist collaboration with a primary care clinic7
Academic detailing with ambulatory pharmacists to support naloxone counseling7
A state-level needs analysis of community pharmacy point-of-care testing7
Impact of pharmacist intervention on completion of recombinant zoster vaccine series in a community pharmacy7
The impact of faculty and student pharmacist relationships on burnout7
Pharmacist peer coaching in a traditional community chain pharmacy: Implementation and perceptions7
Examining Medicare Part D Medication Therapy Management program in the context of mental health7
Community health worker perspectives of an academic community medication therapy management collaboration7
COVID-19 vaccine confidence project7
Evaluation of naloxone furnishing community pharmacies in San Francisco7
Examining nonprescription syringe sales in Massachusetts and Rhode Island community pharmacies7
Association of pharmacist counseling with adherence, 30-day readmission, and mortality: A systematic review and meta-analysis of randomized trials7
Drug and medical device product failures and the stability of the pharmaceutical supply chain7
Access to contraception in pharmacies during the COVID-19 pandemic7
Expanding pharmacists’ roles: Pharmacists’ perspectives on barriers and facilitators to collaborative practice7
Pharmacists’ knowledge, perspectives, and experiences with mifepristone dispensing for medication abortion7
Metabolic monitoring of second-generation antipsychotics: Evaluation of a pharmacist- and nurse-driven protocol7
Meta-analysis comparing inappropriately low dose versus standard dose of direct oral anticoagulants in patients with atrial fibrillation7
Revisiting the continuum of pharmacist prescriptive authority7
Prescription drug disposal: Products available for home use7
Implementation and evaluation of social determinants of health practice models within community pharmacy7
Independent pharmacist prescribing of statins for patients with type 2 diabetes: An analysis of enhanced pharmacist prescriptive authority in Idaho7
The effect of community pharmacist–led health coaching on clinical outcomes7
Psychological impact of the COVID-19 outbreak in community pharmacists: A longitudinal study7
The impact of community pharmacy utilization of immunization information systems on vaccination rates: Results of a clustered randomized controlled trial7
Impact of a communication technique training on rates of naloxone dispensing7
Pharmacy intervention to facilitate transparent opioid-risk and safety communication7
Patient and prescriber perceptions of depression screening within a community pharmacy setting6
The clinical microsystems approach: Does it really work? A systematic review of organizational theories of health care practices6
Effect of drug disposal bag provision on families’ disposal of children’s unused opioids6
The role of the pharmacist in mental health: An investigation of the impact of pharmacist-led interventions on psychotropic medication adherence in patients with diabetes6
Women as first authors in key pharmacy journals: Analysis by publication type6
COVID-19 era of misinformation: When your family does not trust you, will your patients?6
Systematic review of oral pharmacotherapeutic options for the management of uterine fibroids6
Implementation of a pharmacist-delivered Medicare counseling service in a rural community health center6
Pharmacists’ response during a pandemic: A survey on readiness to test during COVID-196
An intersectional review of discrimination and harassment experiences in pharmacy: Findings from the 2019 National Pharmacist Workforce Survey6
Evaluation of an accredited training program on implementation of point-of-care testing in community pharmacies6
Improving access to care via psychiatric clinical pharmacist practitioner collaborative management of buprenorphine for opioid use disorder6
Comparison of naloxone prescribing patterns due to educational outreach conducted by full-time and part-time academic detailers at the U.S. Veterans Health Administration6
A scoping review of the minority stress processes experienced by sexual and gender minority individuals in pharmacy settings: Implications for health care avoidance6
Wrong drug and wrong dose dispensing errors identified in pharmacist professional liability claims6
Exploring the early phase of implementation of a vaccine-based clinical decision support system in the community pharmacy6
Pharmacist eConsult service for primary care medication optimization and safety6
Assistance with injectable medications: Implementation of a pharmacist-run specialty pharmacy injection clinic6
Developing sustainable workflows for community pharmacy–based SARS-CoV-2 testing6
Pharmacists to partner with religious leaders to overcome vaccine hesitancy among Christians6
Older adults’ perceptions of deprescribing chronic benzodiazepines6
Opportunities and responsibilities for pharmacists to improve their effectiveness in addressing medication adherence through culturally sensitive collaborations with community health workers6
Impact of pharmacist counseling to enhance the accessibility of naloxone nasal spray to patients in a community pharmacy setting6
Patient outcomes from implementing an enhanced services pharmacy network6
Pharmacist provider status: Geoprocessing analysis of pharmacy locations, medically underserved areas, populations, and health professional shortage areas6
Implementation and assessment of a pilot, community pharmacy–based, opioid pain medication management program6
Community-based pharmacy use of the Pharmacist eCare Plan: A retrospective review6
Remote pharmacy service in primary care: The implementation of a cloud-based pre-prescription review system6
Expanding the accessibility of harm reduction services in the United States: Measuring the impact of an automated harm reduction dispensing machine6
Opportunities for pharmacist prescriptive authority of buprenorphine following passage of the Mainstreaming Addiction Treatment (MAT) Act6
Mapping the implementation of pharmacogenomic testing in community pharmacies 2003-2021 using the Theoretical Domains Framework: A scoping review6
Reprint of: The role of the pharmacist in mental health: An investigation of the impact of pharmacist-led interventions on psychotropic medication adherence in patients with diabetes6
Expansion of community pharmacies’ role in public vaccine delivery to children: Opportunities and need6
Impact of a pharmacist-run refill and prior authorization program on physician workload6
Perceptions of COVID-19 vaccines in a predominantly Hispanic patient population from the Texas–Mexico border6
Pharmacists improve diabetes outcomes: a randomized controlled trial6
Investigating the impact of student loan debt on new practitioners6
Practice change intentions after academic detailing align with subsequent opioid prescribing6
Factors that influence how adults select oral over-the-counter analgesics: A systematic review6
Pharmacy deserts and patients with breast cancer receipt of influenza vaccines6
Evaluation of knowledge of the new Pregnancy and Lactation Labeling Rule among pharmacists and physicians6
A systematic review of patient interactions with student pharmacists in educational settings6
Pharmacy patient perceptions of pharmacy technicians as immunizers6
Psychometric validation of a growth Mindset and Team Communication Tool to measure self-views of growth mindset and team communication skills6
Assessment of literacy and numeracy skills related to medication labels in patients on chronic in-center hemodialysis6
Effectiveness of an educational intervention on health risks of vaping for high school–aged adolescents5
Weight loss differences seen between glucagon-like peptide–1 receptor agonists and sodium–glucose cotransporter–2 inhibitors for treatment of type 2 diabetes5
Pharmacists’ experiences with a statewide naloxone standing order program in Massachusetts: a mixed methods study5
The “affected” pharmacist and the “business as usual” pharmacist: Exploring the experiences of pharmacists during COVID-19 through cluster analysis5
Educational programs implemented for pharmacists after state passage of a standing order for naloxone: A systematic review of current practices5
Impact of pharmacist motivational interviewing on hepatitis B vaccination in adults with diabetes5
Vitamin C and zinc lozenges for COVID-19?5
Increasing use of immunization information systems for routine vaccinations in independent community pharmacies: A randomized controlled trial5
Characterizing medication management and the role of pharmacists in caring for people living with cystic fibrosis: A work system approach5
Managing college operations during the coronavirus outbreak5
Factors that influence patient acceptance of clinical pharmacy services: A nationwide survey5
Effect of pharmacists’ interventions on health outcomes of children with asthma: A systematic review5
Community pharmacists’ provision of sexual and reproductive health services: A cross-sectional study in Alberta, Canada5
Enhancing adult immunization care by community pharmacists: A qualitative analysis of Project VACCINATE5
Implementation strategies from deployment of the National Diabetes Prevention Program in Pennsylvania community pharmacies5
Integrating targeted consultant pharmacists into a new collaborative care model to reduce the risk of falls in older adults owing to the overuse of opioids and benzodiazepines5
Pilot implementation of the PharmNet naloxone program in an independent pharmacy5
Impact of a pilot community pharmacy system redesign on reducing over-the-counter medication misuse in older adults5
Adult attention deficit hyperactivity disorder clinic: An interprofessional collaboration5
Prescription drug monitoring programs in community pharmacy: An exploration of pharmacist time requirements and labor cost5
A conceptual value-based incentivization model of adult immunization for community pharmacists5
Stability and consistency of compounded oral liquid levothyroxine formulations5
Innovative partnership in Connecticut to expand health professional eligibility to administer COVID-19 vaccines5
Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician5
Pharmacists and community health workers improve medication-related process outcomes among Cambodian Americans with depression and risk for diabetes5
Pharmacists should treat patients who have opioid use disorders, not police them5
Self-care–seeking behaviors in the community pharmacy: A cross-sectional exit survey of Australian consumers5
Addressing buprenorphine bottlenecks in the context of MAT Act implementation: A shared responsibility5
Engaging youth in the design of prescription opioid safety education for schools5
Implementation and impact assessment of integrated electronic prior authorization in an academic health system5
Knowledge about COVID-19 vaccine and vaccination in Vietnam: A population survey5
Patient errors in use of injectable antidiabetic medications: A need for improved clinic-based education5
COVID-19 perceptions and vaccine hesitancy: Acceptance, attitude, and barriers among Cameroonians5
0.045242071151733